Hydra Capital
1010 Wisconsin Ave NW Suite#625, Washington, District of Columbia, 20007, United States
Overview
Hydra Capital is a private equity firm that invests in a range of businesses in the technology, services, and real estate sectors. They seek to support and maximize those opportunities where capital, operational, and management expertise can help drive an organization to its fullest potential.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 0
Sector focus
- Accounting
- Finance
- Financial Services
Investment portfolio
- GenomeNext
Led · Seed · Feb 2016
GenomeNext provides a proprietary bioinformatic pipeline and enterprise cloud platform (offered as SaaS, with private-cloud and custom options) for analyzing, organizing, and managing genomic data. Its computational backbone was developed at Nationwide Children’s Hospital and claims higher speed, sensitivity, specificity, and reproducibility versus traditional methods. The platform demonstrated population-scale capability by analyzing whole genomes and exomes of 2,504 individuals in one week (processing ~1,000 samples/day and generating ~100TB of processed result files). GenomeNext’s pipeline outperformed 21 organizations in the CLARITY Undiagnosed Challenge and has been validated in clinical laboratory services and research initiatives. Customers include genomic research centers, academic institutions, government labs, CROs, pharmaceutical and biotech companies, agrigenomics, and consumer genomics firms. The company plans to expand sales infrastructure and marketing, integrate new tool sets, and evolve its platform to increase commercial and operational capacity.
Team
No current team members are available.